nk-cells

Documents about nk-cells

• Spirulina Oral Supplement for Enhancing Host Resilience to Virus Infection#1045839ClinicalTrials.gov
• Haploidentical Transplantation With Early Adoptive Transfer of CD56+CD3- NK Cells#217033ClinicalTrials.gov
• NKG2D.Zeta-NK Cell Conditioning With C7R.GD2.CAR-T Cells for Patients With Relapsed or Refractory Osteosarcoma or Neuroblastoma#349970ClinicalTrials.gov
• Adaptive Phase 1/2 Study of Dual-Target CAR-NK Cells in Relapsed/Refractory Small Cell Lung Cancer (SCLC)#463723ClinicalTrials.gov
• Comparative analysis of second and third-generation nanobody-based CAR-NK cells targeting PSMA in prostate cancer immunotherapy: In silico and in vitro studies.#636323NCBI PubMed Central
• Post Discharge Trial to Enhance Immunity in Severely Malnourished Children#885709ClinicalTrials.gov
• NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial#913808ClinicalTrials.gov
• Dual-target PSMA/PSCA CAR-NK Cells in Advanced Prostate Cancer#325304ClinicalTrials.gov
• Establishment of a scalable engineered cell-line platform for direct, GMP-grade production of eVLP vectors enabling streamlined generation of gene-edited CAR-T/NK cells.#446228NCBI PubMed Central
• Randomized Study of Haploidentical Hct and Subsequent Donor nk Cell Infusion in High-risk AML and MDS#914776ClinicalTrials.gov
• Clinical Study of HLA Haploidentical CAR-NK Cells Targeting CD19 in the Treatment of Refractory/Relapsed B-cell NHL#812671ClinicalTrials.gov
• Phase 1 Dose Escalation and Expansion Study of TROP2 CAR Engineered IL15-transduced Cord Blood-derived NK Cells in Patients With Advanced Solid Tumors (TROPIKANA)#992102ClinicalTrials.gov
• LFA-1 Interaction with GBP-130 on <i>Plasmodium falciparum</i> -infected Red Blood Cells mediates NK Cell Activation and Parasite Control#152091Unpaywall
• Dual-target CD70/CAIX CAR-NK Cells for Advanced Clear Cell Renal Cell Carcinoma#878720ClinicalTrials.gov
• Clinical Study of Cord Blood-derived CAR-NK Cells Targeting CD19 in the Treatment of Refractory/Relapsed B-cell NHL#917327ClinicalTrials.gov
• Activating mutations of STAT5B and STAT3 in lymphomas derived from ??-T or NK cells.#954783Koc University Digital Collections
• Exercise-induced Effects on Immune Parameters in Healthy Participants#883941ClinicalTrials.gov
• A Clinical Research of NK Cell Infusion Combined With Chemotherapy in the Treatment of Non-small Cell Lung Cancer#1031927ClinicalTrials.gov
• Phase 2 Trial of CD70.CAR NK Cells for Patients With Primary Refractory or Early Relapsed Diffuse Large B-Cell Lymphoma and Hodgkin Lymphoma#848371ClinicalTrials.gov
• NKX019, Intravenous Allogeneic Chimeric Antigen Receptor Natural Killer Cells (CAR NK), in Adults With B-cell Cancers#314321ClinicalTrials.gov
• Phase I/II Study of Engineered T Cell Receptor-Modified NK Cells Targeting PRAME in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Myeloid Malignancies#981665ClinicalTrials.gov
• A PHASE IB STUDY OF IMMUNOTHERAPY WITH EX VIVO PRE-ACTIVATED AND EXPANDED CB-NK CELLS IN COMBINATION WITH CETUXIMAB, IN COLORECTAL CANCER PATIENTS WITH MINIMAL RESIDUAL DISEASE (MRD)#1046018ClinicalTrials.gov
• Trial of ONC-PluReceptor NK Cells With Epcoritamab and Tafasitamab for Patients With Recurrent or Refractory B-cell Non-Hodgkin Lymphoma#895420ClinicalTrials.gov
• T Cells Expressing a Fully-Human Anti-CD30 Chimeric Antigen Receptor for Treating CD30-Expressing Lymphomas#217037ClinicalTrials.gov
• FT516 in Combination With Monoclonal Antibodies in Advanced Solid Tumors#872147ClinicalTrials.gov
• Study of CAR.70-engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Advanced Renal Cell Carcinoma, Mesothelioma and Osteosarcoma#830087ClinicalTrials.gov
• The transcription factor Fli1 restricts the formation of memory precursor NK cells during viral infection#634749eScholarship
• A Study to Evaluate the Safety and Anti-tumor Activity of SNK01 (NK Cells) Administered in Combination With Chemotherapy or Chemotherapy / Cetuximab in Local Advanced or Metastatic Non-small Cell Lung Cancer Patients Who Failed Tyrosine Kinase Inhibitor Treatment#1009384ClinicalTrials.gov
• CAR.CD19-CD28-zeta-2A-iCasp9-IL15-Transduced Cord Blood NK Cells, High-Dose Chemotherapy, and Stem Cell Transplant in Treating Participants With B-cell Lymphoma#230391ClinicalTrials.gov
• Umbilical Cord Blood NK Cells, Rituximab, High-Dose Chemotherapy, and Stem Cell Transplant in Treating Patients With Recurrent or Refractory B-Cell Non-Hodgkin's Lymphoma#181754ClinicalTrials.gov
• Genetically Engineered Natural Killer (NK) Cells With or Without Atezolizumab for the Treatment of Non-small Cell Lung Cancer Previously Treated With PD-1 and/or PD-L1 Immune Checkpoint Inhibitors#121363ClinicalTrials.gov
• NK Cells in Cord Blood Transplantation#877345ClinicalTrials.gov
• Donor T Cells After Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies#837867ClinicalTrials.gov